Zdrowie i gospodarka · 01/06/1999
Oncologic Drugs Advisory Committee; Amendment of Notice
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Oncologic Drugs Advisory Committee. This meeting was announced in the Federal Register of May 20, 1999 (64 FR 27581). The meeting will be open to the public. This amendment is being made to change the meeting starting time and the procedures paragraph and to cancel the closed session.